Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1978-08-28
1979-11-20
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A61K 31545
Patent
active
041751256
ABSTRACT:
Certain halogenated phenylthioacetamido cephalosporanic acids and derivatives thereof, e.g., 7-[2'-(2",5"-dichlorophenylthio)acetamido]cephalosporanic acid, are effective antibiotics against Staphylococcus aureus cultures which show heterogeneous resistance to methicillin.
REFERENCES:
patent: 3234222 (1966-02-01), Fechtig et al.
patent: 3252973 (1966-05-01), Flynn
patent: 3335136 (1967-08-01), Flynn
patent: 3507861 (1970-04-01), Morin et al.
patent: 3536698 (1970-10-01), Chauvette et al.
Eli Lilly and Company
Goldberg Jerome D.
Martens William C.
Smith Everet F.
LandOfFree
Method for treating methicillin resistant staphylococcus aureus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating methicillin resistant staphylococcus aureus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating methicillin resistant staphylococcus aureus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-872974